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Background: Kenya has implemented a robust response to non-communicable diseases 
and injuries (NCDIs); however, key gaps in health services for NCDIs still exist in the 
attainment of Universal Health Coverage (UHC). The Kenya Non-Communicable Diseases 
and Injury (NCDI) Poverty Commission was established to estimate the burden of NCDIs, 
determine the availability and coverage of health services, prioritize an expanded set of 
NCDI conditions, and propose cost-effective and equity-promoting interventions to avert 
the health and economic consequences of NCDIs in Kenya.
Methods: Burden of NCDIs in Kenya was determined using desk review of published 
literature, estimates from the Global Burden of Disease Study, and secondary analysis 
of local health surveillance data. Secondary analysis of nationally representative 
surveys was conducted to estimate current availability and coverage of services by 
socioeconomic status. The Commission then conducted a structured priority setting 
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INTRODUCTION
The focus of the prevention and control of non-communicable diseases (NCDs) has been on four 
major diseases and four risk factors, as framed by the World Health Organization (WHO) in the 
Global Action Plan (GAP) for the Prevention and Control of Non-communicable Diseases in 2013 
[1]. The emphasis on tobacco control, alcohol control, physical activity, and healthy diet as well 
as cardiovascular diseases, cancer, chronic obstructive pulmonary disease, and cancers was put 
forward as a global agenda to consolidate focus on the complex interplay between the socio-
economic, environmental and modifiable behavioral factors that underlie the causation and 
distribution of these chronic conditions.
While this four by four framework has provided valuable guidance to strategic planning and 
activities for the prevention of control of non-communicable diseases and injuries (NCDIs) in 
countries such as Kenya, where these conditions form a considerable share of national morbidity 
and mortality [2], it was recently expanded during the 2018 UN high level meeting to a five by five 
that now includes air pollution and mental health.
However, recent studies have suggested that a large proportion of the global DALYs due to NCDIs 
may be due to risk factors and conditions other than those represented in this framework [3]. This 
differential burden of NCDs and risk factors may be particularly pronounced in younger populations 
and those living in extreme poverty, as is present in a large proportion of the Kenyan population. 
Although data from primary studies is limited, a higher prevalence has been shown in urban and 
wealthier demographic groups in Kenya for several common and lifestyle-associated NCDIs, such 
as hypertension [4], diabetes [5–7], and chronic respiratory diseases [8, 9], as compared to more 
rural populations and lower socioeconomic groups. Meanwhile, the prevalence may be higher for 
several severe and highly disabling NCDI conditions, such as esophageal cancer [10], epilepsy [11], 
mental disorders [12], suicide [13], violent injuries [14, 15], intimate partner violence [16, 17], falls 
[18], animal bites [18], and burns [18, 19].
The economic impact of NCDIs in Kenya is more impoverishing than communicable diseases and 
is more pronounced in the poor [20]. For households reporting NCDs in a nationally-representative 
household survey, 29.9% of those in the lowest quintile experienced catastrophic expenditures 
(defined as >30% of total household income), compared to 9.2% in the highest income quintile 
[21]. The rate of catastrophic expenditure was also higher for rural (20.8%) as compared to urban 
(13.6%) households.
It is in this context that the Kenya NCDI Poverty Commission (herein “Commission”) was established 
and launched by the Kenya Ministry of Health in December 2017, in collaboration with the Lancet 
Commission on Reframing Non-Communicable Diseases and Injuries for the Poorest Billion. The 
Findings: There is a large and diverse burden of NCDIs in Kenya, with the majority of 
disability-adjusted life-years occurring before age of 40. The poorest wealth quintiles 
experience a substantially higher deaths rate from NCDIs, lower coverage of diagnosis 
and treatment for NCDIs, and lower availability of NCDI-related health services. The 
Commission prioritized 14 NCDIs and selected 34 accompanying interventions for 
recommendation to achieve UHC. These interventions were estimated to cost $11.76 
USD per capita annually, which represents 15% of current total health expenditure. This 
investment could potentially avert 9,322 premature deaths per year by 2030.
Conclusions and Recommendations: An expanded set of priority NCDI conditions and 
health sector interventions are required in Kenya to achieve UHC, particularly for 
disadvantaged socioeconomic groups. We provided recommendations for integration 
of services within existing health services platforms and financing mechanisms and 
coordination of whole-of-government approaches for the prevention and treatment 
of NCDIs.
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Commission was comprised of representatives from the Ministry of Health (MOH), academic 
institutions, WHO, World Bank, research institutions, civil society, not-for-profit organizations, 
and other key cross-sectoral stakeholders in NCD control. The intent of this Commission was 
to use existing data sources to best summarize the impact of NCDIs on the health of Kenyans, 
establish the relationship of poverty with NCDIs in Kenya, develop a proposed package of health 
sector interventions to raise the visibility and understanding of this problem among policy makers 
and civil society in Kenya, and inform future planning and resource allocation. We here present 
the key findings and recommendations from the Kenya NCDI Poverty Commission (full report 
available at: http://www.ncdipoverty.org/kenya-report) [22].
METHODS
A literature review on NCDIs was conducted, consisting of all studies published from 2006–2016 
(extended to January 31st, 2017). The search terms corresponded to the Global Burden of Disease 
(GBD) “level 2 NCDI” categories combined with the word “Kenya” [23]. Studies were included if they 
met any of the following criteria: (1) contained data on prevalence, risk or mortality from NCDIs 
preferably stratified by socioeconomic strata or by geographic location; (2) reported distributions 
of types of NCDI cases among admissions and deaths at health facilities; and (3) reported on 
interventions or service delivery models for NCDIs.
The GBD 2016 study was utilized to model and estimate prevalence, disability-adjusted life years 
(DALYs), and percent of total deaths for specific NCDs, injuries, and risk factors [23]. The burden 
distribution was further analyzed by age and year. Data from the Kenya Demographic and Health 
Survey (DHS) were used to gather nationally-representative household surveys that provide data 
for a wide range of monitoring and impact evaluation indicators in the areas of population, health, 
and nutrition [18]. This survey also contained data on tobacco use, alcohol use, and adult nutritional 
status among men and women aged 15–49 years disaggregated by wealth quintile. Data from 
the Kenya Medical Research Institute (KEMRI)/Centers for Disease Control and Prevention (CDC) 
Health and Demographic Surveillance System (HDSS) in rural Siaya County in western Kenya and 
the Nairobi Urban HDSS in two urban slum communities in Nairobi were analyzed to determine 
cause of death and overall death rates due to NCDIs and calculate comparative distribution of 
NCDIs by socioeconomic status [15, 24].
The population in each county living with at least four levels deprivations from an adapted 
Multidimensional Poverty Index (MPI) were used to construct an index of socioeconomic indicators 
from the Kenya DHS, including schooling, school attendance, electricity, sanitation, water, flooring, 
cooking fuel, and household assets [25].
Baseline availability of services was estimated using the 2013 Kenya Service Availability and 
Readiness Assessment (SARA) [26]. Availability of services was analyzed by disease condition, 
level of the health system, rural or urban location, and county. Both reported availability of 
services and readiness by the observed availability of designated tracer items were analyzed. 
The association of the percentage of health facilities with service/medication availability or 
readiness with proportion of households living in poverty per the MPI across counties was tested 
using Pearson’s correlation coefficient and the p-value of the slope from a simple least squares 
regression. Essential medications for NCDIs were obtained from the Kenya Essential Medications 
List 2016 [27]. The Kenya STEP Survey 2015 was reviewed to assess behavioral and metabolic risk 
factors for NCDs [14]. Data from this survey was secondarily analyzed to obtain wealth quintile 
disaggregation for survey questions pertaining to diagnosis and treatment for hypertension and 
diabetes. Availability of referral level services was provided by experts’ report from the members 
of the Commission.
Data regarding national health expenditures were extracted from the Kenya National Health 
Accounts 2015/2016 [28]. These data were reviewed and validated by commissioners to establish 
baseline availability and financing of services.
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KEY FINDINGS
OVERALL BURDEN OF NCDIS IN KENYA
Overall, NCDIs accounted for 37% of the disease burden in DALYs in Kenya with more than half 
(53%) of NCD DALYs and 72% of injury DALYs occurring before the age of 40 (Figure 1). Of all DALYs 
from NCDs, 67% were related to conditions other the four NCDs highlighted in the WHO GAP 
(Figure 2). This is notably higher than in high-income countries, where only 53% of NCD DALYs 
are due to conditions other than these four disease areas [23]. NCD disease categories with the 
highest proportion of DALYs occurring under the age of 40 included mental health disorders (74%), 
neurological disorders (70%), and chronic respiratory diseases (50%). NCDIs were responsible for 
35% of all deaths in Kenya, and 22% of these occurred before the age of 40.
Figure 2 DALYs from NCDs in 
Kenya due to the four NCDs 
included and not included in the 
Global Action Plan (GBD 2016).
Figure 1 Disability-adjusted 
life years due to major disease 
groups, by age (GBD 2016).
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BURDEN OF NCDIS IN RELATION TO SOCIOECONOMIC STATUS
Data from the KEMRI/CDC HDSS in Siaya County, a primarily rural catchment area located in the 
western region of the country from 2003–2016, reported 36.1% of deaths were attributed to NCDs 
and 4.6% were attributed to injuries by verbal autopsy methods. Individuals in the lowest wealth 
quintile had a comparable proportion of deaths due to NCDIs (39.0%) as compared to the highest 
wealth quintile (41.6%) (Figure 3a). The leading causes of NCD deaths among the poorest quintile 
were cancers (32.1%), cardiovascular disease (26.3%), and abdominal causes (16.2%). Using the 
multidimensional poverty index to assess poverty, 39.5% of Kenyans would be considered as living 
in the poorest billion people globally.
Data from the Nairobi Urban HDSS from 2010–2015 demonstrated overall a lower proportion of 
deaths due to NCDs (14%) compared to the rural based Siaya HDSS but a much higher proportion 
of deaths due to injuries (19%). The proportion of deaths due to NCDs was relatively constant 
across wealth quintiles (range: 12.1–15.2%), but the proportion of deaths due to injuries was 
highest in the poorest quintile (22.8%) as compared to the wealthiest quintile (16.9%). Overall, 
crude death rates due to both NCDs and injuries demonstrated a clear socioeconomic trend, with 
increasing death rates associated with increasing level of poverty (Figure 3b).
Figure 3b Crude death rates 
due to NCDs and injuries by 
wealth quintile in Nairobi Urban 
HDSS, 2010–2015 (Source: 
APHRC 2017).
Figure 3a Proportion of cause 
of death by wealth quintile 
in KEMRI/CDC HDSS in Siaya 
County 2003–2016 (source: 
KEMRI/CDC HDSS 2017).
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RISK FACTORS FOR NCDIS IN KENYA
In risk factor modeling from GBD 2016, behavioral and metabolic risk factors, such as tobacco, 
alcohol, obesity and raised blood pressure, accounted for only 21% of DALYs from NCDI conditions 
in Kenya. In this model, 73% of all NCDI DALYs were not attributable to the examined risk factors. 
In regard to DALYs associated with NCDs alone, 23% of these DALYs were attributed to behavioral 
and metabolic risk factors, while the four traditional behavioral risk factors were associated with 
13% of all NCD DALYs. In the categories of digestive diseases, neurologic diseases, musculoskeletal 
diseases, and other NCDs, virtually none of the risk factor profile could be attributed to behavioral 
or metabolic causes (Figure 4). For injuries and mental and substance use disorders, only 10–15% 
of the risk factor profile was attributed to behavioral causes.
Although the categories of neoplasms and cirrhosis had a higher proportion of attributable risks 
to behavioral risk factors (20% and 53%, respectively), which likely represents the relationship 
of smoking with lung cancer and alcohol use with cirrhosis, it is notable that the vast majority 
of neoplasms and almost half of cases of cirrhosis were caused by other risk factors, such as 
chronic infections (human papilloma virus, Epstein Barr virus, hepatitis B and C) or genetic 
Figure 4 Proportion of disability-
adjusted life years in Kenya 
due to risk factor groups in 
each NCDI disease category 
(GBD 2016).
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predispositions. Chronic respiratory diseases had the largest component of risk factors attributable 
to the environment, presumably through air pollution and indoor pollution due to cooking using 
solid fuels (such as wood, crop wastes, charcoal, coal, and dung) and kerosene in open fires and 
inefficient stoves. Although the categories of both cardiovascular disease and diabetes had the 
highest proportion of metabolic risk, metabolic risk alone remained less than half of the risk factor 
profile for each of these categories, which suggests a large component of non-metabolic related 
disease conditions, such as rheumatic heart disease, cardiomyopathies, and type 1 diabetes, 
within these categories.
SERVICE AVAILABILITY FOR NCDIS IN KENYA
Overall, 34% of facilities surveyed in the SARA 2013 health facility survey were considered ready 
for NCD services as measured by the presence of standard precautions, basic amenities, basic 
equipment, and essential medicines. The level of readiness was 51% of hospitals, 51% at health 
centers, 36% at dispensaries, and 21% at medical clinics. A greater proportion of public facilities 
(42%) were considered ready as compared to private not-for-profit (34%) and private for-profit 
(22%) facilities. Overall, all facilities had available 37.1% of components of this readiness package, 
and only 4.9% of facilities had all components available. Compared to other disease areas, 
essential NCD medications were less available at both hospitals (32%) and primary care facilities 
(25%) than medications for malaria (65% and 55%, respectively), tuberculosis (TB) (55% and 51%, 
respectively), and HIV (35% and 47%, respectively) (Figure 5).
Among medications on the national essential medicines list, there was low availability of 
medicines in both urban (31%) and rural health facilities (22%) (Figure 6a). Only glucose injectable, 
furosemide, and paracetamol were more available in the public health facilities. Overall, counties 
with a higher proportion of the population living in the poorest billion had a lower mean number of 
tracer NCD medications available as compared to counties with a lower proportion of population 
living in the poorest billion (r = –0.386, p = <0.01) (Figure 6b). Only the availability of aspirin and 
insulin were not correlated with poverty level in the counties.
The distribution of NCDI referral services listed in Kenya Essential Package for Health (KEPH) and 
specialty physicians throughout the country has not been well quantified, though such resources 
are limited and largely concentrated in urban areas. Expert opinion provided by the Commission 
indicates that currently there were a limited number of referral level services in the public sector in 
Kenya. These include six cardiac surgery centers, twelve centers with capacity for chemotherapy, 
and six radiotherapy centers, though only one radiotherapy center in the public sector. Through the 
“Changing Diabetes in Children” project, there are eight “hubs” providing care for type 1 diabetes 
in the public sector, with 16 “spokes”. Dialysis is more readily available, with approximately 294 
centers around Kenya. Computed tomography (CT) is available at 17 public facilities, and magnetic 
resonance imaging (MRI) at 20 public facilities. Histopathology services are available at most 
Figure 5 Mean availability of 
essential medications for NCDs 
compared to HIV, TB, and 
malaria (Service Availability and 
Readiness Assessment, 2013).
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Figure 6a NCD medication 
availability in all facilities by 
urban or rural categorization 
(Service Availability and 
 Readiness Assessment, 2013).
Figure 6b Percent of facilities 
in each county with the 
mean number of tracer 
medications available for NCDs 
by the percent of the county’s 
population living in the global 
poorest billion (Sources: Service 
Availability and Readiness 
Assessment 2013 and Oxford 
Poverty & Human Development 
Initiative).
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major hospitals, and 11 county hospitals have integrated palliative care services and serve as 
training and mentorship sites for county hospitals [29, 30]. Availability of these services as well as 
specialist physicians per 100,000 population were calculated by the Commission and full results 
are available in the Kenya NCDI Poverty Report [22].
ACCESS AND COVERAGE OF BASIC NCDI SERVICES
According to the Kenya STEP survey 2015, 55.8% of respondents had never had their blood 
pressure measured in the past, and 87.8% had never had their blood sugar measured in the 
past [14]. Access to screening for both hypertension and diabetes was related to wealth quintile, 
with progressively higher proportions never previously screened with increasing poverty level 
(Figure 7). This relationship was also seen when comparing urban and rural populations, with a 
higher proportion of individuals never previously screened in rural areas for both hypertension 
(60.7% vs. 48.1%) and diabetes (89.6% vs. 84.8%). Of those patients found to have hypertension, 
access to treatment was associated with wealth quintile, with poorer populations less likely to 
be on treatment (Figure 7). A higher proportion of patients were screened and on treatment for 
hypertension from urban areas (24.8%) than from rural areas (20.3%) [14].
In regard to coverage of other NCDI services, the distribution of cancer screening suggested a 
socioeconomic trend. In the Kenya DHS 2014, cancer screening was higher among those in the 
wealthiest quintile as compared to those in the poorest quintile for breast cancer (22.7% vs. 4.4%, 
respectively), cervical cancer (22.9% vs. 4.4%), and prostate cancer (3.9% vs. 1.5%) [18]. Screening 
for each of the above cancers was also found to be higher in urban compared to the rural areas.
CURRENT SPENDING ON NCDIS IN KENYA
According to the Kenya National Health Account (NHA) Fiscal Year (FY) 2015/16, total health 
expenditure (THE) in Kenya was $3,475,539,658 USD or $78.60 USD per capita. This THE was 5.2% 
of nominal gross domestic product, and the government expenditure on health was 6.7% of all 
government expenditure. Expenditure on NCDs in FY 2015/16 was $198,568,740 USD, or 5.7% of 
THE ($4.48 USD per capita), a decrease from 6.2% in FY 2012/13. Of this expenditure on NCDs, 
45% of revenue for financing schemes was from the government, 31% from employers, 20% from 
households, and 5% from international sources. Two-fifths (40%) of the expenditures for NCDs 
were incurred in government health facilities while 34% was incurred in private health facilities. 
About half (48%) of NCD expenditures were for outpatient curative care services, 29% for inpatient 
curative care, and 9% for preventive care. Expenditure on injuries in 2015/16 was an additional 
3.7% of THE ($2.91 USD per capita), a decrease from 4.1% in FY 2012/13 [28].
Figure 7 Access to diagnosis for 
hypertension and diabetes and 
treatment for hypertension, by 
wealth quintile (STEPS 2013).
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PRIORITY NCDI INTERVENTIONS FOR UNIVERSAL HEALTH 
COVERAGE
The Commission undertook a process to prioritize among NCDIs conditions for the Kenya health 
sector based on principles of priority setting established by the WHO Consultative Group on Equity 
and Universal Health Coverage (UHC) [31]. The Commission analyzed and ranked NCDI conditions 
based on the estimated burden of disease of each condition in Kenya as measured by DALYs in 
the GBD 2016 [23]. The severity of each condition was measured using the average years of life 
lost (YLL) per death, and the disability of each condition was measured using the years of life with 
disability (YLDs) per incident case. The impact in Kenya compared to high-income countries was 
estimated for each condition by comparing the rate of DALYs per 100,000 population. A total of 190 
NCDI conditions from the GBD database were analyzed by these metrics, and a summary score 
was provided to each condition according to the average of the ranking quartiles on each metric. 
The 50 conditions with the highest summary score were then reviewed by a sub-committee of the 
Commission. The commissioners then selected a final set of 14 conditions based on: 1) their ability 
to contribute significantly to adverse health and economic consequences in Kenya, 2) how feasible 
and effectively they can be controlled in Kenya, and 3) their being complementary to ongoing 
strategy and efforts by the Government of Kenya (GoK) as per the national health policy and NCD 
strategic plan. The selected conditions are shown in Table 1.
Information regarding evidence-based and cost-effective health sector interventions for NCDIs 
was obtained from Disease Control Priorities 3 (DCP3) [32]. The unit cost for each intervention was 
provided on average across low-income countries, which is described in greater detail elsewhere 
[33]. Tradable costs were adjusted for the cost of health sector expenditure in Kenya, and an 
estimated 50% indirect cost was added to the total cost for each intervention. These interventions 
were reviewed by the Commission for 1) alignment with stated NCDI priority conditions, and 
2) feasibility and desirability in the Kenya context. Each intervention was assigned a baseline 
coverage in Kenya, estimated from existing data sources as well as expert experience from the 
commissioners. With consultation from national and regional health managers, the Commission 
then assigned a feasible target coverage for each intervention by the year 2030. The total cost of 
implementing these interventions and premature deaths averted was then calculated [34].
The total annual cost of the incremental increase in coverage represented by this package is 
estimated to be $520,146,154 USD, or approximately KSh 54.7 billion (Table 2). This package of 
DISEASE CATEGORY PRIORITIZED DISEASE/CONDITION
Respiratory Asthma
Chronic obstructive pulmonary disease
Cardiovascular – behavioral & 
metabolic etiologies
Hypertension, Hypertensive heart disease, Ischemic heart disease, hemorrhagic 
stroke, ischemic stroke
Cardiovascular – other etiologies Rheumatic heart disease
Endocrine Diabetes mellitus (type 1 and 2)
Cancers Cervical cancer
Burkitt lymphoma (non-Hodgkin lymphoma)
Breast cancer
Mental Health Major depressive disorder
Neurologic Epilepsy
Congenital Sickle cell disorders
Liver “Cirrhosis” – etiologies include hepatitis B, hepatitis C, alcohol, other causes
Surgical & Injuries Motor vehicle road injuries
Assault
Table 1 Selected priority NCDIs 
for service expansion.
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Table 2 Selected priority interventions for NCDIs with cost-effectiveness rating, financial risk protection 
rating, equity rating, total cost for estimated population in need, estimated baseline coverage, assigned 
target coverage, and calculated incremental cost.
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interventions would represent a 2.6-fold increase in the current expenditure on NCD services as 
reported by the NHA 2015/16, which would comprise 15.0% of the current total health expenditure. 
Overall, this package of interventions, which includes outpatient, inpatient, surgical, mental 
health, rehabilitation, and palliative care services would represent an incremental investment 
of $11.76 per capita annually. Using mortality impact estimation methodology described by the 
DCP3 group, these interventions, if implemented to target coverage, are projected to avert 9,322 
premature deaths per year by the year 2030. This figure represents an approximate 10% reduction 
in expected premature deaths by the year 2030 (according to 2015 death rates).
DISCUSSION
The findings of this Commission suggest that NCDIs comprise a large share of the burden of 
disease in Kenya and affect the population at younger ages than commonly believed. The burden 
of NCDI conditions is very diverse, and the majority of NCD DALYs in Kenya are due to conditions 
other than the four emphasized in global monitoring frameworks. While behavioral risk factors 
have a large attributable risk for NCDs, the findings of this Commission show that most of the NCDI 
disease burden in Kenya cannot be directly attributed to individual lifestyle choices using existing 
data sources. Data from HDSS sites from both rural and urban contexts demonstrate an equal, if 
not higher, proportion of deaths due to NCDIs in the poorest as compared to wealthiest quintiles. 
Furthermore, crude death rates among the poor were more than double for NCDs and triple for 
injuries than that among the wealthier populations.
The Kenyan National Strategy for the Prevention and Control of NCDs 2015–2020 went beyond the 
WHO GAP framework in including additional conditions, such as violence and injuries, palliative care, 
mental disorders, cognitive impairment, renal disorders, hepatic disorders, endocrine disorders, 
neurological conditions, hemoglobinopathies, gastroenterological, musculoskeletal, skin disorders, 
oral diseases, disabilities including visual and hearing impairment, and genetic disorders [35]. 
The Kenya Essential Package for Health also followed this model by developing a comprehensive 
package of services for NCDIs at multiple tiers of the health system [36]. However, this Commission 
found that availability of key medications and readiness of NCD services remains limited and 
inversely related to the poverty level of regions. Coverage of basic NCDIs, such as diagnosis and 
treatment of hypertension and diabetes or cancer screening, is low, and is inversely related to 
wealth. Domestic financing for NCDIs was also limited and not commensurate to the burden.
The interventions selected and prioritized by this Commission will require design, implementation, 
integration, and scale of a complex set of health sector interventions, some of which already exist 
within the health care system, and others that have yet to be introduced. Although this package 
of interventions for NCDIs is quite comprehensive, including surgical, mental health, rehabilitation, 
and palliative care services, it would represent only a 15.0% increase in total health expenditure or 
$11.76 per capita annually. This level of additional expenditure for NCDIs may not be unreasonable 
in the setting of recent recommendations for government expenditure on health care, such as 5% 
of GDP or a per capita expenditure of $86 USD in low-income countries [37].
These interventions, if implemented to target coverage, are projected to avert 9,322 premature 
deaths per year by the year 2030. This figure represents an approximate 10% reduction in expected 
premature deaths in the year 2030 (according to 2015 death rates). However, although this figure 
provides a reasonable estimate of averted deaths, given the greater number of interventions 
selected by the Kenya NCDI Poverty Commission than the DCP3 high-priority essential package, 
this figure is likely underestimated. Furthermore, this analysis does not include averted morbidity, 
which would be considerably greater than averted mortality, and provide substantial benefit to 
many more individuals, particularly given the emphasis on interventions for severe conditions 
affecting those at younger ages.
The majority of interventions selected for introduction or scale up would be applied at the 
primary care or health center level. Essential components to the introduction and scale-up of 
these interventions are many, and would include infrastructure, staffing, training, guidelines, 
medications, equipment, diagnostics, and referral networks. However, most of these interventions 
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exist at some baseline level in public health sector facilities, though availability and readiness 
may vary dramatically. Integration with existing infrastructure and personnel for other chronic 
diseases, such as antiretroviral therapy for HIV/AIDS, maternal and child services and surgical 
services may facilitate integration of other chronic disease services for chronic NCDs and mental 
health conditions [38].
Health system interventions alone are not sufficient to prevent the risk and impact of NCDIs as 
well as provide care for NCDs on the Kenyan community, and a truly comprehensive response to 
NCDIs in Kenya requires a whole-of-government approach. In conjunction with the findings of this 
Commission, a national NCD inter-sectoral coordinating mechanism was launched to foster inter-
sectoral interventions and to harness the support and synergies from outside of the health sector. 
This inter-sectoral committee adopted the recommendations of this Commission and is working 
towards broadening Kenya’s attention beyond the traditional NCDI behavioral risk factors and a 
more comprehensive approach rooted in equity. The recommended interventions require local 
adaptation and integration into existing health services platforms, coupled with development and 
strengthening of human resource capacity, supply chains, and referral pathways.
Mitigating the impoverishing effects of NCDIs will require the expanded coverage of the national 
social insurance program, establishment and strengthening of social safety nets for the poor, and 
increased focus on more equitable access to both preventive and curative health services through 
coherent cross-sectoral policies and plans. There is need to expand investment in the NCDI response 
via increases in direct domestic financing through capitation, insurance revenues, and innovative 
financing mechanisms and partnerships. With these recommendations, this Commission believes 
that an expansive reframing of NCDIs will allow for a comprehensive and equitable response to 
NCDIs in hopes of realization of the broader goal of UHC for the Kenyan population.
COMPETING INTERESTS
The authors have no competing interests to declare.
AUTHOR CONTRIBUTIONS
Gene Bukhman and Neil Gupta contributed equally to this manuscript. All the authors participated 
in the preparation of the manuscript.
AUTHOR AFFILIATIONS
Kibachio Mwangi  orcid.org/0000-0003-3725-1762 
Division of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya 
Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland 
World Health Organization (WHO) South Africa Country Office, South Africa
Gladwell Gathecha  orcid.org/0000-0001-9669-0226 
Division of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya
Mary Nyamongo  orcid.org/0000-0001-8359-5596 
African Institute of Health and Development, Nairobi, Kenya
Sylvester Kimaiyo  orcid.org/0000-0003-4957-1253 
Academic Model Providing Access to Healthcare, Eldoret, Kenya
Jemima Kamano  orcid.org/0000-0003-2179-8202 
Academic Model Providing Access to Healthcare, Eldoret, Kenya
Fredrick Bukachi  
Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, Kenya
Frank Odhiambo  orcid.org/0000-0003-3056-8425 
Kenya Medical Research Institute, Nairobi, Kenya
Hellen Meme  
Kenya Medical Research Institute, Nairobi, Kenya
Hussein Abubakar  
Field Epidemiology and Laboratory Training Program, Nairobi, Kenya
14Mwangi et al.
Annals of Global Health  
DOI: 10.5334/aogh.3085
Nelson Mwangi  
Field Epidemiology and Laboratory Training Program, Nairobi, Kenya
Joyce Nato  orcid.org/0000-0003-3292-8834 
World Health Organization Country Office, Nairobi, Kenya
Samuel Oti  orcid.org/0000-0003-1035-9511 
International Development Research Center, Nairobi, Kenya
Catherine Kyobutungi  orcid.org/0000-0002-5344-5631 
African Population and Health Research Center, Nairobi, Kenya
Marylene Wamukoya  orcid.org/0000-0002-2900-9178 
African Population and Health Research Center, Nairobi, Kenya
Shukri F. Mohamed  orcid.org/0000-0002-8693-1943 
African Population and Health Research Center, Nairobi, Kenya
Emma Wanyonyi  
International Institute for Legislative Affairs, Nairobi, Kenya
Zipporah Ali  orcid.org/0000-0003-3643-0304 
Kenya Hospices and Palliative Care Association, Nairobi, Kenya
Loise Nyanjau  orcid.org/0000-0002-9608-8494 
Division of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya
Ann Nganga  orcid.org/0000-0002-6217-6955 
Division of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya
Dorcas Kiptui  
Division of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya
Alfred Karagu  orcid.org/0000-0003-0321-9879 
Division of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya
Mary Nyangasi  orcid.org/0000-0003-1889-0702 
Division of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya
Valerian Mwenda  orcid.org/0000-0002-1956-7440 
Division of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya
Martin Mwangi  orcid.org/0000-0002-5398-3472 
Division of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya;  
Field Epidemiology and Laboratory Training Program, Nairobi, Kenya
Aaron Mulaki  
RTI International, Nairobi, Kenya
Daniel Mwai  orcid.org/0000-0002-6750-9480 
School of Economics, University of Nairobi, Nairobi, Kenya
Paul Waweru  orcid.org/0000-0001-6312-2126 
Kenya National Bureau of Statistics, Nairobi, Kenya
Mamka Anyona  orcid.org/0000-0002-4704-9018 
Program in Global Non-Communicable Diseases and Social Change, Department of Global Health and Social 
Medicine, Harvard Medical School, Boston, USA
Peninah Masibo  orcid.org/0000-0001-5404-1711 
Global Programs for Research and Training Affiliate of The University of California San Francisco, USA; 
Moi University School of Public Health, Eldoret, Kenya
David Beran  orcid.org/0000-0001-7229-3920 
Division of Primary Care Medicine, Geneva University Hospital and University of Geneva, Geneva, Switzerland
Idris Guessous  orcid.org/0000-0002-0491-6089 
Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland;  
Division of Tropical and Humanitarian Medicine, University of Geneva and Geneva University Hospitals, 
Geneva, Switzerland
Matt Coates  orcid.org/0000-0002-8474-4992 
Program in Global Non-Communicable Diseases and Social Change, Department of Global Health and Social 
Medicine, Harvard Medical School, Boston, USA
Gene Bukhman  orcid.org/0000-0003-4500-7903 
Program in Global Non-Communicable Diseases and Social Change, Department of Global Health and Social 
Medicine, Harvard Medical School, Boston, USA;  
NCD Synergies, Partners in Health, Boston, USA
Neil Gupta  orcid.org/0000-0003-3470-5351 
Program in Global Non-Communicable Diseases and Social Change, Department of Global Health and Social 
Medicine, Harvard Medical School, Boston, USA;  
NCD Synergies, Partners in Health, Boston, USA
15Mwangi et al.
Annals of Global Health  
DOI: 10.5334/aogh.3085
REFERENCES
1. World Health Organization. Global action plan for the prevention and control of noncommunicable 
diseases 2013–2020. World Health Organization; 2013. 
2. Achoki T, Miller­Petrie MK, Glenn SD, et al. Health disparities across the counties of Kenya and 
implications for policy makers, 1990–2016: A systematic analysis for the Global Burden of Disease Study 
2016. The Lancet Global Health. January 1, 2019; 7(1): e81–95. DOI: https://doi.org/10.1016/S2214-
109X(18)30472-8
3. Bukhman G, Mocumbi AO, Horton R. Reframing NCDs and injuries for the poorest billion: A Lancet 
Commission. Lancet. 2015; 386(10000): 1221–2. DOI: https://doi.org/10.1016/S0140-6736(15)00278-0
4. Hulzebosch A, van de Vijver S, Oti SO, Egondi T, Kyobutungi C. Profile of people with hypertension in 
Nairobi’s slums: A descriptive study. Globalization and Health. December 1, 2015; 11(1): 26. DOI: https://
doi.org/10.1186/s12992-015-0112-1
5. Ayah R, Joshi MD, Wanjiru R, et al. A population-based survey of prevalence of diabetes and correlates 
in an urban slum community in Nairobi, Kenya. BMC Public Health. December 2013; 13(1): 1–1. DOI: 
https://doi.org/10.1186/1471-2458-13-371
6. Mathenge W, Foster A, Kuper H. Urbanization, ethnicity, and cardiovascular risk in a population in 
transition in Nakuru, Kenya: A population-based survey. BMC Public Health. December 1, 2010; 10(1): 
569. DOI: https://doi.org/10.1186/1471-2458-10-569
7. Ploubidis GB, Mathenge W, De Stavola B, Grundy E, Foster A, Kuper H. Socioeconomic position and 
later life prevalence of hypertension, diabetes, and visual impairment in Nakuru, Kenya. International 
Journal of Public Health. February 1, 2013; 58(1): 133–41. DOI: https://doi.org/10.1007/s00038-012-
0389-2
8. Ait‐Khaled N, Odhiambo J, Pearce N, et al. Prevalence of symptoms of asthma, rhinitis, and eczema in 
13‐to-14‐year‐old children in Africa: The International Study of Asthma and Allergies in Childhood Phase 
III. Allergy. March 2007; 62(3): 247–58. DOI: https://doi.org/10.1111/j.1398-9995.2007.01325.x
9. Esamai F, Ayaya S, Nyandiko W. Prevalence of asthma, allergic rhinitis, and dermatitis in primary 
school children in Uasin Gishu district, Kenya. East African Medical Journal. 2002; 79(10): 514–8. DOI: 
https://doi.org/10.4314/eamj.v79i10.8812
10. Patel K, Wakhisi J, Mining S, Mwangi A, Patel R. Esophageal cancer, the topmost cancer at MTRH in 
the Rift Valley, Kenya, and its potential risk factors. International Scholarly Research Notices. 2013. DOI: 
https://doi.org/10.1155/2013/503249
11. Mbuba CK, Ngugi AK, Fegan G, et al. Risk factors associated with the epilepsy treatment gap in Kilifi, 
Kenya: A cross-sectional study. The Lancet  Neurology. August 1, 2012; 11(8): 688–96. DOI: https://doi.
org/10.1016/S1474-4422(12)70155-2
12. Jenkins R, Othieno C, Ongeri L, et al. Common mental disorder in Nyanza province, Kenya in 2013 
and its associated risk factors–an assessment of change since 2004, using a repeat household survey 
in a demographic surveillance site. BMC  Psychiatry. December 1, 2015; 15(1): 309. DOI: https://doi.
org/10.1186/s12888-015-0693-5
13. Jenkins R, Othieno C, Omollo R, et al. Tedium vitae, death wishes, suicidal ideation, and attempts in 
Kenya-prevalence and risk factors. BMC Public Health. December 1, 2015; 15(1): 759. DOI: https://doi.
org/10.1186/s12889-015-2089-3
14. Kenya Ministry of Health. Kenya Stepwise Survey for Noncommunicable Diseases Risk Factors 2015 
Report. Division of Noncommunicable Diseases, Kenya Ministry of Health, 2015.
15. Africa Population Health Research Center.  Nairobi Urban Health Demographic Surveillance  System 
Indicators 2003–2015. Nairobi: African  Population and Health Research Center; 2017.
16. Bamiwuye SO, Odimegwu C. Spousal  violence in sub-Saharan Africa: Does household  poverty-wealth 
matter? Reproductive Health. December 1, 2014; 11(1): 45. DOI: https://doi.org/10.1186/1742-4755-
11-45
17. Lawoko S, Dalal K, Jiayou L, Jansson B. Social inequalities in intimate partner violence: A study 
of women in Kenya. Violence and Victims.  December 1, 2007; 22(6): 773–84. DOI: https://doi.
org/10.1891/088667007782793101
18. Kenya National Bureau of Statistics, Ministry of Health, National AIDS Control Council, et al. Kenya 
Demographic and Health Survey 2014. 2015. https://www.dhsprogram.com/pubs/pdf/FR308/FR308.pdf. 
Accessed September 20, 2018.
19. Ombati AN, Ndaguatha PL, Wanjeri JK. Risk factors for kerosene stove explosion burns seen at 
Kenyatta National Hospital in Kenya. Burns. May 1, 2013; 39(3): 501–6. DOI: https://doi.org/10.1016/j.
burns.2012.07.008
16Mwangi et al.
Annals of Global Health  
DOI: 10.5334/aogh.3085
TO CITE THIS ARTICLE: 
Mwangi K, Gathecha G, 
Nyamongo M, Kimaiyo S, 
Kamano J, Bukachi F, Odhiambo 
F, Meme H, Abubakar H, Mwangi 
N, Nato J, Oti S, Kyobutungi C, 
Wamukoya M, Mohamed SF, 
Wanyonyi E, Ali Z, Nyanjau L, 
Nganga A, Kiptui D, Karagu A, 
Nyangasi M, Mwenda V, Mwangi 
M, Mulaki A, Mwai D, Waweru P, 
Anyona M, Masibo P, Beran D, 
Guessous I, Coates M, Bukhman 
G, Gupta N. Reframing Non-
Communicable Diseases and 
Injuries for Equity in the Era 
of Universal Health Coverage: 
Findings and Recommendations 
from the Kenya NCDI Poverty 
Commission. Annals of Global 
Health. 2021; 87(1): 3, 1–16. 
DOI: https://doi.org/10.5334/
aogh.3085
Published: 05 January 2021
COPYRIGHT: 
© 2021 The Author(s). This is an 
open-access article distributed 
under the terms of the Creative 
Commons Attribution 4.0 
International License (CC-BY 
4.0), which permits unrestricted 
use, distribution, and 
reproduction in any medium, 
provided the original author 
and source are credited. See 
http://creativecommons.org/
licenses/by/4.0/.
Annals of Global Health is a peer-
reviewed open access journal 
published by Ubiquity Press.
20. Mwai D, Muriithi M. Economic effects of non- communicable diseases on household income in Kenya: 
A comparative analysis perspective. Public Health Res. 2016; 6(3): 83–90.
21. Mwai D, Muriithi M. Catastrophic health expenditure and household impoverishment: A case of NCDs 
prevalence in Kenya. Epidemiology, Biostatistics, and Public Health. Mar 21, 2016; 13(1).
22. Kenya Ministry of Health. The Kenya Non-Communicable Diseases & Injuries Poverty Commission 
Report. Kenya Ministry of Health; 2018. http://www.ncdipoverty.org/kenya-report.
23. Institute for Health Metrics and Evaluation (IHME). GBD Compare. Seattle, WA: IHME, University of 
Washington; 2015. http://vizhub.healthdata.org/gbd-compare. Accessed December 4, 2017.
24. Kenya Medical Research Institute (KEMRI) & Centers for Disease Control (CDC) Health Demographic 
Surveillance Site (HDSS). Data provided courtesy of KEMRI Director. 2017.
25. Alkire S, Robles G. Global Multidimensional  Poverty Index 2017. OPHI Briefing 47, 2017.
26. Government of Kenya. Kenya Service  Availability and Readiness Assessment Mapping (SARAM). Kenya 
Ministry of Health; 2014.
27. Kenya Ministry of Health. Kenya Essential  Medicines List 2016. Kenya Ministry of Health; 2016.
28. Kenya Ministry of Health. Kenya National Health Accounts 2015/2016. Kenya Ministry of Health; 2017. 
29. Korir A, Okerosi N, Ronoh V, Mutuma G,  Parkin M. Incidence of cancer in Nairobi, Kenya (2004–2008). 
International Journal of Cancer. Nov 1, 2015; 137(9): 2053–9. DOI: https://doi.org/10.1002/ijc.29674
30. Ali Z. Kenya Hospices and Palliative Care Association: Integrating palliative care in public hospitals in 
Kenya. Ecancermedicalscience. 2016; 10. DOI: https://doi.org/10.3332/ecancer.2016.655
31. World Health Organization. Making fair choices on the path to universal health coverage: Final 
report of the WHO Consultative Group on Equity and Universal Health Coverage. World Health 
Organization; 2014.
32. Jamison DT, Alwan A, Mock CN, et al. Universal health coverage and intersectoral action for health: 
key messages from Disease Control Priorities. The Lancet. Mar 17; 2018; 391(10125): 1108–20. DOI: 
https://doi.org/10.1016/S0140-6736(15)60097-6
33. Watkins D, Qi J, Horton S. Costs and affordability of essential universal health coverage in low-and 
middle-income countries. Disease Control Priorities. 2017. http://dcp-3.org/resources/costs-and-
affordability-essential-universal-health-coverage-low-and-middle-income.
34. Watkins DA, Norheim OF, Jha P, Jamison DT. Mortality Impact of Acheiving Essential Universal Health 
Coverage in Low-and Lower Middle-Income Countries. Disease Control Priorities. 2017. http://dcp-3.org/
resources/mortality-impact-achieving-essential-universal-health-coverage-low-and-middle-income.
35. Kenya Ministry of Health. Kenyan National  Strategy for the Prevention and Control of NCDs 2015–2020. 
Kenya Ministry of Health; 2015.
36. Kenya Ministry of Medical Services and Kenya Ministry of Public Health & Sanitation. Accelerating 
Attainment of Health Goals: The Kenya Health Sector Strategic and Investment Plan: July 2013–June 
2017. Kenya Ministry of Medical Services and Ministry of Public Health & Sanitation; 2012.
37. Meheus F, McIntyre D. Fiscal space for domestic funding of health and other social services. Health 
Economics, Policy and Law. April 2017; 12(2): 159–77. DOI: https://doi.org/10.1017/S1744133116000438
38. Gupta N, Bukhman G. Leveraging the lessons learned from HIV/AIDS for coordinated chronic care 
delivery in resource-poor settings. Healthcare. 2015; 3(4): 215–20. DOI: https://doi.org/10.1016/j.
hjdsi.2015.09.006
